Skip to main content
Clinical Trials/CTRI/2023/01/048921
CTRI/2023/01/048921
Recruiting
未知

An investigation into metabolomics of prostate cancer patients to identify diagnostic and prognostic biomarkers for disease burden and therapeutic outcome, and development of metabolomics database

AIIMS New Delhi0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: C61- Malignant neoplasm of prostate
Sponsor
AIIMS New Delhi
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational

Investigators

Sponsor
AIIMS New Delhi

Eligibility Criteria

Inclusion Criteria

  • 1\) Patients aged \>\= 18 years
  • 2\) Prostate cancer Any T, any N, M0 or M1

Exclusion Criteria

  • 1\.Patients who are not willing to participate and will not provide signed informed consent
  • 2\.Patients with metabolic disorders
  • 3\.Thyrotoxicosis patients
  • 4\.Patients with uncontrolled DM, defined as HbA1c \>\=7\.5%
  • 5\.Patients with hepatic dysfunction that is those in whom serum bilirubin will be more than 1\.5 and, AST and ALT will be more than 2\.5 fold higher than the upper limit of normal at baseline
  • 6\.Patients in whom serum creatinine will be more than 1\.5 fold higher than the upper limit of normal

Outcomes

Primary Outcomes

Not specified

Similar Trials